Unknown

Dataset Information

Interleukin-36 family dysregulation drives joint inflammation and therapy response in psoriatic arthritis.


ABSTRACT:

Objectives

IL-36 agonists are pro-inflammatory cytokines involved in the pathogenesis of psoriasis. However, their role in the pathogenesis of arthritis and treatment response to DMARDs in PsA remains uncertain. Therefore, we investigated the IL-36 axis in the synovium of early, treatment-naïve PsA, and for comparison RA patients, pre- and post-DMARDs therapy.

Methods

Synovial tissues were collected by US-guided biopsy from patients with early, treatment-naïve PsA and RA at baseline and 6 months after DMARDs therapy. IL-36 family members were investigated in synovium by RNA sequencing and immunohistochemistry, and expression levels correlated with DMARDs treatment response ex vivo. Additionally, DMARDs effects on IL-36 were investigated in vitro in fibroblast-like synoviocyt

SUBMITTER: Boutet MA 

PROVIDER: S-EPMC7188345 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature